NEW ORLEANS -- In an interview at the Society of Nuclear Medicine and Molecular Imaging annual meeting, Phillip Kuo, MD, PhD, of the City of Hope in Duarte, CA, discussed new appropriate use criteria for amyloid and tau PET imaging in Alzheimer’s disease patients.
Video from SNMMI: Phillip Kuo on new Alzheimer’s disease imaging guidelines
Latest in Molecular Imaging
Appropriate use criteria issued for FET-PET brain imaging
November 13, 2026
SPECT-guided algorithm can aid in assessing Lu-177 RPT responses
November 12, 2026
SNMMI, QMIC partner on quantitative PET and SPECT standards
November 11, 2026




















